Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1].
Molecular Weight:
355.39
Purity:
99.30
CAS Number:
[2321488-47-3]
Formula:
C18H21N5O3
Target:
JAK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted